<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000443046"><TermName>velafermin</TermName><TermPronunciation>(veh-luh-FER-min)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the prevention and treatment of oral mucositis (sores in the mouth) in patients receiving high-dose chemotherapy. Velafermin belongs to the family of drugs called recombinant human fibroblast growth factors (rhFGF).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000714666" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;velafermin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000714667" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;velafermina&quot;" language="es" id="_4"/><SpanishTermName>velafermina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para la prevención y el tratamiento de la mucositis oral (llagas en la boca) de los pacientes que reciben quimioterapia de dosis alta. La velafermina es un tipo de factor de crecimiento de fibroblastos recombinante (rhFGF, por sus siglas en inglés).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-04-20</DateFirstPublished></GlossaryTerm>
